
Associate Director, US Oncology Marketing, Operational Excellence & Capacity Planning
Merck
Summary
The U.S. Oncology business is a growing and dynamic organization committed to advancing innovative therapies for patients with cancer. This role supports the potential U.S. launch of an mRNA-based individualized neoantigen therapy for early-stage melanoma, developed through an alliance partnership.
Job description
Reporting to the Director, Individualized Therapy Operations, this individual serves as the commercial lead for operational demand planning, capacity planning, scenario modeling, performance management, and analytics across the Intismeran treatment ecosystem. This leader will establish and oversee the capabilities, processes, and governance required to support operational planning, performance management, and data-driven decision making across the treatment journey.
Key Responsibilities
- Lead operational demand planning and capacity planning for Intismeran, developing patient volume projections, manufacturing demand assumptions, network capacity plans, and business scenarios to support launch readiness, commercialization, and future growth.
- Partner with Manufacturing, Supply Chain, Precision Medicine, alliance stakeholders, and external partners to align projected demand with manufacturing availability and operational readiness, proactively identifying risks and recommending mitigation strategies.
- Develop and maintain capacity planning and scenario modeling capabilities, assessing the impact of changing demand, treatment site expansion, manufacturing constraints, and operational capacity on treatment completion and business performance.
- Establish and oversee the operational intelligence framework for the Intismeran treatment journey, including performance dashboards, operational KPIs, demand and capacity models, executive reporting, and control tower analytics.
- Translate complex operational, logistics, manufacturing, customer, and market data into actionable business insights and strategic recommendations.
- Lead operational performance management and business review processes, evaluating demand-plan assumptions, capacity utilization, treatment completion performance, operational cycle times, partner effectiveness, and overall ecosystem performance.
- Drive operational excellence and continuous improvement initiatives across the treatment ecosystem, leveraging analytics and predictive insights to strengthen demand and capacity planning, optimize capacity, enhance operational efficiency, mitigate risk, and support long-term scalability.
Education
Bachelor's degree or equivalent (BA/BS) required; MBA or equivalent preferred.
Required Experience and Skills
- Minimum of 5 years of experience in pharmaceutical or biotechnology industries, including experience supporting commercial organizations in operational planning, capacity planning, analytics, or treatment operations.
- Demonstrated experience leading operational planning, capacity planning, demand planning, business analytics, or operational excellence initiatives that require coordination across multiple internal functions and external partners.
- Experience developing and managing operational performance frameworks, including KPIs, dashboards, scorecards, business reviews, performance metrics, and executive reporting.
- Proven ability to translate complex operational, manufacturing, customer, and market data into actionable business insights and strategic recommendations.
- Strong analytical, strategic thinking, and problem-solving capabilities, with demonstrated success identifying operational risks, evaluating tradeoffs, and developing data-driven recommendations in complex environments.
- Exceptional communication and stakeholder management skills, with the ability to influence without direct authority and effectively communicate insights and recommendations to leadership.
- Demonstrated ability to manage ambiguity, balance competing priorities, and drive execution in dynamic launch, growth, or transformation environments.
Preferred Skills
- Experience supporting the commercialization of complex therapies, including cell therapy, gene therapy, radioligand therapy, or other highly coordinated treatment models.
- Experience in manufacturing planning, demand planning, integrated business planning, sales and operations planning (S&OP), supply chain operations, or capacity management.
- Experience developing operational intelligence capabilities, including dashboards, executive reporting, KPI frameworks, business reviews, or operational performance measurement systems.
Requirements
- Minimum of 5 years of experience in pharmaceutical or biotechnology industries
- Experience supporting commercial organizations in operational planning, capacity planning, analytics, or treatment operations
- Demonstrated experience leading operational planning, capacity planning, demand planning, business analytics, or operational excellence initiatives
- Experience developing and managing operational performance frameworks including KPIs, dashboards, scorecards, business reviews, and executive reporting
- Proven ability to translate complex operational, manufacturing, customer, and market data into actionable business insights
- Strong analytical, strategic thinking, and problem-solving capabilities
- Exceptional communication and stakeholder management skills
- Ability to influence without direct authority
- Demonstrated ability to manage ambiguity and balance competing priorities
- Bachelor's degree or equivalent (BA/BS)
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.